CAMBRIDGE, England--(BUSINESS WIRE)--Nuclera, the biotechnology company accelerating protein expression and optimization through its benchtop eProtein Discovery™ system, and Domainex, a multi-award ...
Nuclera, the biotechnology company accelerating drug discovery by providing rapid, easy access to functional proteins through its benchtop eProtein Discovery™ System, today announced that it has ...
Cambridge, UK and Marlborough, MA, 28 May 2025: Nuclera, the biotechnology company accelerating protein expression and optimization through its benchtop eProtein Discovery™ System, has announced a ...
A Compact Benchtop Optofluidic System with Lower Cost of Ownership for Broader Research Accessibility EMERYVILLE, Calif.--(BUSINESS WIRE)-- Bruker Corporation (BRKR) (Nasdaq: BRKR) today announced the ...
The eProtein Discovery™ system empowers you to know what protein has the best chance of success for every project from the start. Combining unique cell free expression systems, novel digital ...
Bruker Corporation today announced the launch of the Beacon Discovery ™ Optofluidic System at the upcoming American Association for Cancer Research (AACR) Annual Meeting 2025. This new Beacon benchtop ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results